Back to Archived Journals » Core Evidence » Volume 2 » Issue 3
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 2, 2007
Abatacept: the evidence for its place in the treatment of rheumatoid arthritis
Marcus D. Köller
Core Evidence 2007, 2:0-0
Published Date: 15 September 2007
Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome
Mark Waterlow, Paul Chrisp
Core Evidence 2007, 2:0-0
Published Date: 15 September 2007
Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
Giuseppe Derosa, Sibilla Anna Teresa Salvadeo
Core Evidence 2007, 2:0-0
Published Date: 15 September 2007
Eritoran: the evidence of its therapeutic potential in sepsis
Shahzad G. Raja, Gilles D. Dreyfus
Core Evidence 2007, 2:0-0
Published Date: 15 September 2007
Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease
Andrea Cassinotti, Sandro Ardizzone, Gabriele Bianchi Porro
Core Evidence 2007, 2:0-0
Published Date: 15 September 2007
Infliximab: the evidence for its place in therapy in ulcerative colitis
Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
Core Evidence 2007, 2:0-0
Published Date: 15 September 2007